We aimed to investigate the efficacy of preemptive
analgesia of
celecoxib on
postoperative pain, patients' global assessment (
PGA) and hip function recovery compared to postoperative
analgesia of
celecoxib in
femoroacetabular impingement (FAI) patients who underwent hip arthroscopy surgery (HAS). The 100 FAI patients underwent HAS were randomly allocated to preemptive
analgesia group (N = 50) or postoperative
analgesia group (N = 50) as a 1:1 ratio for 3 months.
Pain visual analog scale (VAS) score,
PGA score, rescue-use
pethidine consumption and Harris hip score were assessed. Compared to postoperative
analgesia group,
pain VAS score decreased on day 1 (P = 0.036), day 2 (P = 0.046) and day 3 (P = 0.046), while was similar prior to operation (P = 0.587), on day 7 (P = 0.398), at month 1 (P = 0.461) and month 3 (P = 0.805) in preemptive
analgesia group. Besides, rescue-use
pethidine consumption was decreased in preemptive
analgesia group than postoperative
analgesia group within 3 days (P = 0.016) and within 7 days (P = 0.033) post-operation. For
PGA score, it reduced on day 2 (P = 0.030) and day 3 (P = 0.048), while was similar prior to operation (P = 0.699), on day 1 (P = 0.699), day 7 (P = 0.224), at month 1 (P = 0.640) and month 3 (P = 0.400) in preemptive
analgesia group than postoperative
analgesia group. For Harris hip score, it was similar prior to operation (P = 0.372), on day 7 (P = 0.366), at month 1 (P = 0.466) and month 3 (P = 0.658) between the two groups. In conclusion, preemptive
analgesia of
celecoxib decreases short-term
postoperative pain and
PGA, but without effect on long-term hip function recovery than postoperative
analgesia of
celecoxib in FAI patients who underwent HAS.